NCT03764527View on ClinicalTrials.gov

Tolerability and Efficacy of Artemether-Lumefantrine Versus Artesunate + Amodiaquine in Zanzibar

PHASE4CompletedINTERVENTIONAL
Enrollment

408

Participants

Timeline

Start Date

November 1, 2002

Primary Completion Date

February 17, 2003

Study Completion Date

February 17, 2003

Conditions
Plasmodium Falciparum Malaria
Interventions
DRUG

Artemether-lumefantrine

Two doses a day for 3 days, under supervision

DRUG

Coadministered Artesunate plus Amodiaquine

One dose a day for 3 days, under supervision

All Listed Sponsors
collaborator

Zanzibar Malaria Control Programme

OTHER_GOV

collaborator

World Health Organization

OTHER

lead

Professor Anders Björkman

OTHER

NCT03764527 - Tolerability and Efficacy of Artemether-Lumefantrine Versus Artesunate + Amodiaquine in Zanzibar | Biotech Hunter | Biotech Hunter